EarningsQ1 2023 Earnings Report

Novartis (NVSN) Q1 2023 Earnings Report

0 Followers

MX:NVSN Q1 2023 EPS Results

Actual EPS$29.19

Consensus EPS$26.14

Beat/MissBeat by +$3.04

One Year Ago EPS$24.92

Actual Revenue$233.76B

Expected Revenue$228.97B

Beat/MissBeat by +$4.79B

YoY Revenue Growth+3.61%

QuarterQ1 2023

Date04/25/2023

TimeBefore Open

Conference CallTuesday, April 25, 2023

MX:NVSN Upcoming Earnings

Novartis's next earnings date is estimated for October 27, 2026, based on past reporting schedules.

MX:NVSN Q1 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 27, 2026	2026 (Q3)	40.83 / -	40.511	―
Jul 21, 2026	2026 (Q2)	39.11 / 43.39	43.571	-0.41% (-0.18)
Apr 28, 2026	2026 (Q1)	37.77 / 35.83	41.051	-12.72% (-5.22)
Feb 04, 2026	2025 (Q4)	35.70 / 36.55	35.649	2.53% (+0.90)
Oct 28, 2025	2025 (Q3)	40.92 / 40.51	37.09	9.22% (+3.42)
Jul 17, 2025	2025 (Q2)	42.33 / 43.57	35.469	22.84% (+8.10)
Apr 29, 2025	2025 (Q1)	38.06 / 41.05	32.408	26.67% (+8.64)
Jan 31, 2025	2024 (Q4)	32.50 / 35.65	27.547	29.41% (+8.10)
Oct 29, 2024	2024 (Q3)	34.89 / 37.09	31.328	18.39% (+5.76)
Jul 18, 2024	2024 (Q2)	33.31 / 35.47	31.22	13.61% (+4.25)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed